Hello, Welcome to Shine Consultant !
Conference Sponsor
319
2020 - 02 - 28
点击次数:
MabPlex International, LTD. has a construction area of 40000m2 and a land area of 28 acres. After phaseⅡproject completed by 2018, the new antibody production lines will have 12 2000L single-use bioreactors and corresponding purification and filling equipment. The ADC production line will have the largest facility (150L conjugation volume) in Asia. These can meet our customers’ need for Phase Ⅲ clinical studies and commercial production. Mabplex provides one-step and high-quality CRO/CMO solutions for biologics to our global clients from R&D to production and drug registration. Supported by our large-scale protein expression and purification techniques and our ADC platform, we not only help our clients accelerate marketing approval by shortening R&D cycles and reducing R&D costs, but also support their marketing needs by consistently delivering large volume and high quality batches at competitive prices. MabPlex’s quality systems strictly follow GMP requirements by USA/EU/Chinese regulatory authorities. Our antibody CMO services can meet our customers’ need for IND filing and PhaseⅠ-Ⅲ clinical studies in USA,EU,AND China.
320
2019 - 09 - 24
点击次数:
Dr. Jim Li is chief executive officer of Sundia. In this role, Dr. Li is responsible for the oversight of all business divisions across the organization as well as formulating and driving key strategies for diversifying and growing the company. Dr. Li also leads the company’s executive committee, helping to drive Sundia’s overall global strategy.Dr. Li has led a distinguished career in the pharmaceutical industry, having spent over 18 years at various companies including Henkel, Wyeth, Pfizer and Wuxi Apptec in the area of process research and medicinal chemistry. During his career, he was involved in numerous drug discovery programs such as COPD, asthma, Rheumatoid/osteoarthritis, and diabetes. Dr. Li has co-authored more than 60 research articles and patents.Dr. Li received his Ph.D in Organic Chemistry from University of Central Lancashire UK followed by a postdoctoral fellow at the University of Chicago with Dr. Philip Eaton.
321
2019 - 09 - 06
点击次数:
Beijing Haike Rongtong Payment Service Co., Ltd. was established in 2001, with a registered capital of 258.8 million yuan, specialized in the third-party payment, Internet finance, value-added service,obtained 'The payment business license' issued by the People's Bank of China in 2011, has a nationwide operating third-party payment business qualification, and renewed in 2016.With the spirit of 'good faith, practical,  innovation, highly effective' , forward-looking strategic view and high social responsibility, Haike Rongtong has been actively promoting domestic financial services, and gradually becomes the leader of the global third-party payment terminal market